Examining the Long-term Clinical Evidence of Therapies for Inflammatory Bowel Disease in Bio-naïve Patients : Episode 16

Video

July 19, 2023

Treatment Sequencing for UC

Author(s):

David P. Hudesman, MD,Maia Kayal, MD

Experts offer clinical advice on therapy sequencing of Janus kinase (JAK) inhibitors for ulcerative colitis (UC) and when surgery may be appropriate.

EP: 1.Overview of IBD

EP: 2.Treatment Factors of IBD

EP: 3.Managing Care for IBD Patients Not Responding to Treatment

EP: 4.Selecting First-Line Treatments for CD

EP: 5.The Role of Vedolizumab and Risankizumab in CD

EP: 6.Efficacy and Safety of Ustekinumab for CD

EP: 7.Selecting Therapies for CD in Pregnancy

EP: 8.Selecting Treatments in Patients With EIM

EP: 9.Second-Line Therapies for CD

EP: 10.Optimizing Therapies for CD

EP: 11.Major Takeaways for Treating CD

EP: 12.Treatment Approaches for Patients With UC

EP: 13.The Role of Ozanimod in UC

EP: 14.The Role of Ustekinumab in UC

EP: 15.Utilizing JAK Inhibitors in Patients With UC

EP: 16.Treatment Sequencing for UC

EP: 17.Biosimilar Treatment Options for Patients With UC

EP: 18.Key Takeaways and Prospective Treatment Advances

Related Videos

Jessica Crimaldi, NP | Credit: Jessica Crimaldi on LinkedIn

Andrea Banty, NP, DNP

Lisa Richards, MSN, FNP-BC | Credit: UC San Diego

Nicole Martinez de Andino, NP | Credit: Wellstar MCG Health

Taha Qazi, MD | Credit: Cleveland Clinic

Taha Qazi, MD | Credit: Cleveland Clinic

William Grady, MD | Credit: Fred Hutchinson Cancer Center

Edward V Loftus, Jr, MD | Credit: Mayo Clinic

Taha Qazi, MD | Credit: Cleveland Clinic

Related Content

Related Content

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.